Pharsight Monthly Summary
JUNE, 2024
Recent happenings in patent protected drugs.
spacer_11
At a Glance
66
drug patents lapsed
Photos
60
new drug patents introduced
Reviews
spacer_11
Companies who recently launched drugs
 
 
ABBVIE
 
ARCUTIS
 
AXSOME MALTA
 
BAUSCH
 
BIOGEN IDEC
 
BIOXCEL
 
BRISTOL
 
CHIESI
 
CMP DEV LLC
 
DECIPHERA PHARMS
 
EVOFEM INC
 
FENNEC PHARMS INC
 
GALDERMA LABS LP
 
GERON
 
GILEAD SCIENCES INC
 
IPSEN
 
JANSSEN BIOTECH
 
JAZZ
 
JAZZ PHARMS
 
LABS FARMS ROVI SA
 
MAIA PHARMS INC
 
MEDICINES360
 
NALPROPION
 
NOVO
 
PYROS PHARMS
 
SPRINGWORKS
 
VIIV HLTHCARE
 
 
spacer_11
Drugs not protected by their main patents
Drug Company
ABILIFY OTSUKA
ABILIFY MYCITE KIT OTSUKA
ADASUVE ALEXZA PHARMS
ADDYI SPROUT PHARMS
ADLYXIN SANOFI-AVENTIS US
AGGRASTAT MEDICURE
ALDARA BAUSCH
ARNUITY ELLIPTA GLAXOSMITHKLINE
AURYXIA KERYX BIOPHARMS
AXUMIN BLUE EARTH
BRILINTA ASTRAZENECA
CLEVIPREX CHIESI
COPAXONE TEVA PHARMS USA
DALIRESP ASTRAZENECA
DEXILANT TAKEDA PHARMS USA
DEXILANT SOLUTAB TAKEDA PHARMS USA
DIPRIVAN FRESENIUS KABI USA
ELELYSO PFIZER
EMEND MSD MERCK CO
EPIVIR VIIV HLTHCARE
FERAHEME COVIS
FLONASE SENSIMIST ALLERGY RELIEF HALEON US HOLDINGS
GADAVIST BAYER HLTHCARE
GILENYA NOVARTIS
GLEEVEC NOVARTIS
IQIRVO IPSEN
IRESSA ASTRAZENECA
JADENU SPRINKLE NOVARTIS
JUXTAPID CHIESI
LEVEMIR FLEXTOUCH NOVO NORDISK INC
LIPTRUZET ORGANON
LUMASON BRACCO
LYRICA CR UPJOHN
MACRILEN NOVO
MOVIPREP SALIX PHARMS
MYRBETRIQ GRANULES APGDI
NEXIUM 24HR ASTRAZENECA LP
NORDITROPIN FLEXPRO NOVO NORDISK INC
NOURIANZ KYOWA KIRIN
NOVOLOG FLEXTOUCH NOVO NORDISK INC
NOXAFIL MERCK SHARP DOHME
OMONTYS TAKEDA PHARMS USA
OMONTYS PRESERVATIVE FREE TAKEDA PHARMS USA
ORBACTIV MELINTA THERAP
PEPAXTO ONCOPEPTIDES AB
RAPIVAB BIOCRYST
REYATAZ BRISTOL MYERS SQUIBB
SAXENDA NOVO
SELZENTRY VIIV HLTHCARE
SOLIQUA 100/33 SANOFI-AVENTIS US
SOMAVERT PHARMACIA
SPIRIVA RESPIMAT BOEHRINGER INGELHEIM
SYNRIBO TEVA PHARMS INTL
TORISEL PF PRISM CV
TRUVADA GILEAD
VARITHENA PROVENSIS
VASCEPA AMARIN PHARMS
VELPHORO VIFOR FRESENIUS
VENLAFAXINE BESYLATE ALMATICA
VICTRELIS MERCK SHARP DOHME
VIIBRYD ABBVIE
VYVANSE TAKEDA PHARMS USA
XARELTO JANSSEN PHARMS
XEGLYZE HATCHTECH
XEPI FERRER INTERNACIONAL
XOPENEX HFA LUPIN
XTORO FONSECA BIOSCIENCES
ZYVOX PFIZER
Drug patents lapsed
Drug Patent Patent expiry
ABILIFY 8017615 Jun, 2024
ABILIFY 8017615 Jun, 2024
ABILIFY 8017615 Jun, 2024
ABILIFY 8017615 Jun, 2024
ABILIFY 8017615 Jun, 2024
ABILIFY 8017615 Jun, 2024
ABILIFY 8017615 Jun, 2024
ABILIFY 8017615 Jun, 2024
ABILIFY 8017615 Jun, 2024
ABILIFY 8017615 Jun, 2024
ABILIFY MYCITE KIT 8017615 Jun, 2024
ABILIFY MYCITE KIT 8017615 Jun, 2024
ABILIFY MYCITE KIT 8017615 Jun, 2024
ABILIFY MYCITE KIT 8017615 Jun, 2024
ABILIFY MYCITE KIT 8017615 Jun, 2024
ABILIFY MYCITE KIT 8017615 Jun, 2024
ABRAXANE 7923536*PED Jun, 2024
ABRAXANE 8138229*PED Jun, 2024
ABRAXANE 8314156*PED Jun, 2024
ADMELOG SOLOSTAR 8992486 Jun, 2024
APIDRA SOLOSTAR 8992486 Jun, 2024
BELVIQ 8946207 Jun, 2024
BELVIQ XR 8946207 Jun, 2024
ILEVRO 7947295 Jun, 2024
LANTUS SOLOSTAR 8992486 Jun, 2024
MOVANTIK 7056500 Jun, 2024
MOVANTIK 7056500 Jun, 2024
NUVIGIL 7132570*PED Jun, 2024
NUVIGIL 7132570*PED Jun, 2024
NUVIGIL 7132570*PED Jun, 2024
NUVIGIL 7132570*PED Jun, 2024
NUVIGIL 7132570*PED Jun, 2024
PEPAXTO 6992207 Jun, 2024
SOLIQUA 100/33 8992486 Jun, 2024
TOUJEO MAX SOLOSTAR 8992486 Jun, 2024
TOUJEO SOLOSTAR 8992486 Jun, 2024
TPOXX 8124643 Jun, 2024
TPOXX 8530509 Jun, 2024
TPOXX 8802714 Jun, 2024
TPOXX 8124643 Jun, 2024
TPOXX 8530509 Jun, 2024
TPOXX 8802714 Jun, 2024
XIFAXAN 7045620 Jun, 2024
XIFAXAN 7612199 Jun, 2024
XIFAXAN 7902206 Jun, 2024
XIFAXAN 8158644 Jun, 2024
XIFAXAN 8158781 Jun, 2024
XIFAXAN 8835452 Jun, 2024
XIFAXAN 8853231 Jun, 2024
XIFAXAN 7045620 Jun, 2024
XIFAXAN 7612199 Jun, 2024
XIFAXAN 7902206 Jun, 2024
XIFAXAN 8158644 Jun, 2024
XIFAXAN 8158781 Jun, 2024
XIFAXAN 8835452 Jun, 2024
XIFAXAN 8853231 Jun, 2024
XIFAXAN 7045620 Jun, 2024
XIFAXAN 7612199 Jun, 2024
XIFAXAN 7902206 Jun, 2024
XIFAXAN 8158644 Jun, 2024
XIFAXAN 8158781 Jun, 2024
XIFAXAN 8835452 Jun, 2024
XIFAXAN 8853231 Jun, 2024
XYREM 7668730 Jun, 2024
XYREM 7765106 Jun, 2024
XYREM 7765107 Jun, 2024
Newly introduced Drug Patents
Drug Patent Patent expiry
AKEEGA 11986468 Jul, 2037
AKEEGA 11986469 Jul, 2037
AKEEGA 11992486 Jul, 2037
AUGTYRO 10294242 Jul, 2036
AUGTYRO 11452725 Jul, 2036
AUGTYRO 9714258 Jan, 2035
BORTEZOMIB 12005069 Sep, 2042
CONTRAVE 11998542 Jul, 2034
DUOBRII 11986527 Nov, 2031
EPSOLAY 11986456 Feb, 2040
IGALMI 11998528 Jan, 2043
IQIRVO 11185519 Mar, 2037
IQIRVO 11331292 Mar, 2037
IQIRVO 11850223 Mar, 2037
IQIRVO 11857523 Mar, 2037
IQIRVO 7632870 Sep, 2024
IQIRVO 7943661 Sep, 2024
JULUCA 12011506 Sep, 2038
LILETTA 12004992 Oct, 2033
LIQREV 12005062 Dec, 2038
MYCAPSSA 11986529 Sep, 2029
NORLIQVA 12005141 Feb, 2041
OGSIVEO 12011434 May, 2043
OGSIVEO 12011435 May, 2043
PEDMARK 11992530 Jul, 2039
PEDMARK 11998604 Jul, 2039
PHEXXI 11992472 Mar, 2033
QINLOCK 12023325 Aug, 2040
QINLOCK 12023326 Aug, 2040
QINLOCK 12023327 Aug, 2040
QINLOCK 12023328 Dec, 2040
RINVOQ 11976077 Oct, 2036
RINVOQ 11993605 Oct, 2036
RINVOQ 11993606 Oct, 2036
RINVOQ LQ 10981923 Oct, 2036
RINVOQ LQ 11186584 Oct, 2036
RINVOQ LQ 11661425 Oct, 2036
RINVOQ LQ 11680069 Oct, 2036
RINVOQ LQ 11718627 Oct, 2036
RINVOQ LQ 11773105 Oct, 2036
RINVOQ LQ 8962629 Jan, 2031
RINVOQ LQ 9951080 Oct, 2036
RISVAN 11752094 May, 2031
RYTELO 7494982 Dec, 2025
RYTELO 9375485 Mar, 2033
RYTELO 9388415 Sep, 2024
RYTELO 9388416 Sep, 2024
SPINRAZA 12013403 Mar, 2036
SUNOSI 12005036 Dec, 2042
VEKLURY 11975012*PED Nov, 2041
VEKLURY 11975017*PED Jan, 2039
VIGAFYDE 12016857 Aug, 2039
WEGOVY 12029779 Oct, 2038
XYREM 11986446 Mar, 2033
XYWAV 11986446 Mar, 2033
ZORYVE 11992480 Jun, 2037
ZORYVE 12005051 Jun, 2037
ZORYVE 12005052 Jun, 2037
ZORYVE 12011437 Jun, 2037
ZORYVE 12016848 Jun, 2037
What's new on Pharsight!

Find the answers you need on Drugs.

Are you looking for accurate and reliable information on drugs and generics? Look no further! Our FAQ page is packed with answers to some of the most commonly asked questions about drugs. Visit and bookmark our FAQ page today!

Bonus - Don't see your question answered there? Contact us, and we'll be happy to help!

Check out FAQ page

Shoot first, and win big! Figure out the drugs that are about to enter the NCE-1 period to stay ahead of your generic launch strategy!

Want to be first-to-market with your generic drugs? Stay ahead of the game with our exclusive list of drugs facing patent challenges updated every month.

Check out NCE-1 period list

spacer_11

Our insights are consumed by 1000+ leading pharma companies

© 2024 GreyB Research